Valuation: Hologic, Inc.

Market Cap 16.97B 14.92B 13.89B 12.75B 23.95B 1,627B 24.26B 165B 64.46B 804B 63.7B 62.33B 2,777B P/E 2024
24.3x
P/E 2025 27x
Enterprise Value 17.39B 15.29B 14.23B 13.07B 24.54B 1,668B 24.86B 169B 66.06B 823B 65.28B 63.87B 2,846B EV / Sales 2024
4.74x
EV / Sales 2025 3.75x
Free-Float
73.08%
Yield 2024 *
-
Yield 2025 -
1 day+0.48%
6 months+1.08%
Current year+2.04%
Current year 74.49
Extreme 74.49
76.07
1 year 63.19
Extreme 63.1923
76.07
3 years 51.9
Extreme 51.9
84.67
5 years 51.9
Extreme 51.9
87.88
10 years 26.49
Extreme 26.49
87.88
Manager TitleAgeSince
Chief Executive Officer 63 07/04/2026
Director of Finance/CFO - 16/04/2026
Chief Operating Officer 46 01/01/2024
Director TitleAgeSince
Director/Board Member 63 07/04/2026
Date Insider Type Main position Quantity % Market Cap.
07/04/26 Issuer sale

Chief Operating Officer

242,362 0.1086%
07/04/26 Issuer sale

Director

19,583 0.0088%
07/04/26 Issuer sale

Executive/Senior Manager

123,246 0.0552%
Change 5-day change 1-year change 3-year change Capi.($)
+0.48%-.--%+14.30%-5.45% 16.97B
-1.54%+6.33%+16.98%-0.09% 211B
+2.61%-2.29%-4.37%-23.02% 135B
+5.73%+1.04%-28.04%+10.28% 119B
+2.85%+3.98%-57.12%-13.54% 65.77B
+0.50%-2.31%+3.80%+0.45% 47.58B
+1.43%+0.59%-25.87%-33.53% 44.44B
-0.49%+5.86%+14.74%+8.87% 39.14B
-0.93%+3.82%+22.53%+30.15% 36.79B
-2.38%+2.59%+73.35%-0.12% 29.37B
Average +0.83%+1.16%+3.03%-2.60% 74.51B
Weighted average by Cap. +1.17%+1.53%-1.70%-3.88%

Financials

2024 2025
Net sales 4.03B 3.54B 3.3B 3.03B 5.69B 387B 5.76B 39.2B 15.31B 191B 15.13B 14.8B 660B 4.1B 3.6B 3.36B 3.08B 5.79B 393B 5.86B 39.89B 15.58B 194B 15.39B 15.06B 671B
Net income 790M 694M 646M 593M 1.11B 75.71B 1.13B 7.68B 3B 37.39B 2.96B 2.9B 129B 566M 497M 463M 425M 798M 54.25B 809M 5.5B 2.15B 26.79B 2.12B 2.08B 92.59B
Net Debt 321M 282M 263M 241M 453M 30.81B 459M 3.13B 1.22B 15.21B 1.21B 1.18B 52.59B 421M 370M 344M 316M 594M 40.36B 602M 4.09B 1.6B 19.93B 1.58B 1.55B 68.89B
Logo Hologic, Inc.
Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.
Employees
7,070
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
AA
  1. Stock Market
  2. Stocks
  3. HOLX Stock